Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
View Patent ↗Dental dressing assemblies are formed from hydrophilic polymer sponge structures, such as a densified chitosan biomaterial. The invention also contemplates systems and methods that can be used in conjunction with stents and periodontal dressings to promote hemostasis and secondary healing in free gingival graft palatal donor sites and all other oral and maxillofacial surgical sites.
1. A compliant hydrophilic polymer sponge structure having a moisture content of 5% moisture or less and shaped, sized, and configured for use in periodontal free gingival graft structural procedures;
wherein the hydrophilic sponge structure has been densified by compression prior to use to a density of between 0.6 to 0.1 g/cm 3 and comprises a chitosan biomaterial that is not crosslinked and forms an adhesive in situ upon contact with any one of blood, fluid, and moisture.
2. A structure according to claim 1 wherein said structure further promotes soft tissue healing.
3. A structure according to claim 1 wherein said structure further promotes bone healing.
4. A structure according to claim 1 wherein said structure further comprises a platform for the delivery of a therapeutic agent.
5. A method comprising placing the hydrophilic polymer sponge of claim 1 within a periodontal wound site.
6. An assembly for use in a periodontal procedure for treating a wound site, said assembly comprising:
a compliant hydrophilic sponge structure densified by compression prior to use to a density of between 0.6 to 0.1 g/cm 3 , having a moisture content of 5% moisture or less, and comprising a chitosan material that is not crosslinked, wherein the sponge is capable of being applied to said wound site, and forming an adhesive in situ upon contact with any one of blood, fluid, and moisture; and
a structure for covering the sponge structure;
wherein the structure for covering the sponge structure comprises a stent.
7. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial further comprises at least one of glutamic acid, lactic acid, formic acid, hydrochloric acid, and acetic acid.
8. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial further comprises one of hydrochloric acid and acetic acid.
9. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial further comprises a medication or physiologic or pharmacologic agent that acts locally or systemically in the body.
10. The structure according to claim 9 wherein the medication or physiologic or pharmacologic agent is at least one of enzymes, organic catalysts, ribozymes, organometallics, proteins, glycoproteins, peptides, polyamino acids, antibodies, nucleic acids, steroidal molecules, antibiotics, antimycotics, cytokines, growth factors for tissue and/or bone, carbohydrates, oleophobics, lipids, extracellular matrix and/or individual components, mammalian cells, stem cells, genetically engineered cells, pharmaceuticals, and therapeutics.
11. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial has been densified by heat compression at a temperature between about 60° C. and 85° C.
12. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial has been densified by compression prior to use to a density of 0.20 g/cm3.
13. The structure according to claim 12 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial has been densified by heat compression at a temperature between about 60° C. and 85° C.
14. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial is mechanically manipulated for improved compliance and flexibility.
15. The structure according to claim 6 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial is mechanically manipulated for improved compliance and flexibility.
16. The structure according to claim 1 wherein the compliant hydrophilic polymer sponge structure comprising a chitosan biomaterial is preconditioned at a temperature between about 75° C. and about 85° C.